NeuroPn Therapeutics is working on novel and improved therapies for the treatment of neurodegenerative diseases with focus on painful peripheral neuropathy and Parkinson's disease
Acute and chronic pain
NeuroPn is developing a novel, potentially disease modifying appraoch to treat chronic neuropathic pain.
In addition, NeuroPn has identified novel combination of currently marketed drugs (non-opioid) to treat acute in hospital pain with efficacy comparable to opioid drugs
NeuroPn's enzyme inhibition approach shows marked improvement in locomotor activity and significant inhibition of neuronal degeneration; differentiating from current satandard of care (L-DOPA)